Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Expands Rosetta Alliance, Targets Growth In DNA Microarray Market

Premium

P

ALO ALTO, Calif.--Agilent Technologies here announced the expansion of its alliance with Rosetta Inpharmatics to include Rosetta’s FlexJet DNA microarray technology. This announcement follows an earlier agreement between the two companies to develop and distribute Rosetta’s gene expression analysis software platform, the Rosetta Resolver Expression Data Analysis System. As a complement to its own inkjet array technology used to develop catalog type arrays, Agilent will further develop, manufacture, and distribute the FlexJet arrays.

Filed under

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.